Related Experiment Videos
Hyaluronan in canine arthropathies
1Department of Veterinary Pathology, University of Liverpool, UK.
Journal of Comparative Pathology
|August 1, 1994
Summary
Serum and synovial fluid hyaluronan (HA) levels were measured in dogs with joint diseases. Despite changes in HA, significant overlap with normal dogs makes it unsuitable for diagnosing canine arthropathies.
Area of Science:
- Veterinary Medicine
- Biochemistry
- Orthopedics
Background:
- Soluble hyaluronan (HA) is a potential biomarker for joint disease in humans.
- Investigating HA levels in canine arthropathies could offer diagnostic insights.
Purpose of the Study:
- To measure serum and synovial fluid (SF) hyaluronan (HA) in dogs with osteoarthritis (OA), rheumatoid arthritis (RA), cranial cruciate ligament (CCL) rupture, and healthy controls.
- To evaluate the diagnostic and prognostic utility of HA measurements in canine joint diseases.
Main Methods:
- Serum and SF samples were collected from dogs with various arthropathies and control dogs.
- Hyaluronan concentrations were quantified using established laboratory assays.
- Statistical analysis was performed to compare HA levels between groups.
Main Results:
- Dogs with OA, RA, and CCL rupture showed significantly increased serum HA and decreased SF HA compared to controls.
- In OA cases, SF HA was lower in affected joints than in unaffected contralateral joints.
- Dogs with liver disease also exhibited elevated serum HA concentrations.
- A significant overlap in HA values was observed between diseased and normal dogs.
Conclusions:
- While serum and SF HA levels change in canine arthropathies, the significant overlap with normal values limits their diagnostic and prognostic value.
- Hyaluronan measurement is unlikely to be a reliable tool for diagnosing or predicting outcomes in canine joint diseases.